A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. - Wenham RM; Buras AL; Gordon SW; Whiting J; Fridley BL; Dorman D; Apte SM; Chon HS; Shahzad MM; Randall LM; Havrilesky LJ; Davidson BA; et al. (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2026)